Literature DB >> 27119959

[Focal therapy for penile cancer].

O W Hakenberg1, C Protzel2.   

Abstract

BACKGROUND: Focal therapies for superficial penile cancer are today important treatments since organ preservation in penile cancer has a much higher priority than it used to. Because a local recurrence does not substantially influence long-term tumour-specific survival, a slightly higher risk of local recurrence is accepted in favour of maximum organ sparing. THERAPY: Topical chemotherapy and laser ablation can be used for carcinoma in situ, while laser ablation and surgical options are used for Ta/T1 tumours. Radiotherapeutic options can be used, but carry a much higher rate of local complications and lower local control rates.

Entities:  

Keywords:  Brachytherapy; Chemotherapy, topical; Neoplasm recurrence, local; Organ preservation; Radiotherapy

Mesh:

Substances:

Year:  2016        PMID: 27119959     DOI: 10.1007/s00120-016-0079-4

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  18 in total

1.  [Therapeutic alternatives in the treatment of class T1N0 squamous cell carcinoma of the penis: indications and limitations].

Authors:  L Piva; N Nicolai; A Di Palo; A Milani; M Merson; R Salvioni; S Stagni; D Vecchio; F Zanoni; S Ferri; G Pizzocaro
Journal:  Arch Ital Urol Androl       Date:  1996-06

2.  Conservative surgery for squamous cell carcinoma of the penis: resection margins and long-term oncological control.

Authors:  Prodromos Philippou; Majid Shabbir; Peter Malone; Raj Nigam; Asif Muneer; David J Ralph; Suks Minhas
Journal:  J Urol       Date:  2012-07-19       Impact factor: 7.450

3.  Glans resurfacing for the treatment of carcinoma in situ of the penis: surgical technique and outcomes.

Authors:  Majid Shabbir; Asif Muneer; Jas Kalsi; Chitranjan J Shukla; Evangelos Zacharakis; Giulio Garaffa; David Ralph; Suks Minhas
Journal:  Eur Urol       Date:  2010-10-20       Impact factor: 20.096

4.  EAU guidelines on penile cancer: 2014 update.

Authors:  Oliver W Hakenberg; Eva M Compérat; Suks Minhas; Andrea Necchi; Chris Protzel; Nick Watkin
Journal:  Eur Urol       Date:  2014-11-01       Impact factor: 20.096

5.  Penile brachytherapy: results for 49 patients.

Authors:  Juanita M Crook; John Jezioranski; Laval Grimard; Bernd Esche; G Pond
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-06-01       Impact factor: 7.038

6.  Intermediate-differentiated invasive (pT1 G2) penile cancer--oncological outcome and follow-up.

Authors:  Boris Schlenker; Derya Tilki; Christian Gratzke; Michael Seitz; Oliver Reich; Peter Schneede; Christian G Stief; Edwin Hungerhuber
Journal:  Urol Oncol       Date:  2009-11-27       Impact factor: 3.498

7.  Combined laser treatment for penile carcinoma: results after long-term followup.

Authors:  Torgny Windahl; Swen-Olof Andersson
Journal:  J Urol       Date:  2003-06       Impact factor: 7.450

8.  Penile carcinoma. Is Nd:YAG laser therapy radical enough?

Authors:  D Frimberger; E Hungerhuber; D Zaak; R Waidelich; A Hofstetter; P Schneede
Journal:  J Urol       Date:  2002-12       Impact factor: 7.450

9.  pT1 penile squamous cell carcinoma: a clinicopathologic study of 56 cases treated by CO2 laser therapy.

Authors:  Maurizio Colecchia; Nicola Nicolai; Piercesare Secchi; Gaetano Bandieramonte; Anna Maria Paganoni; Laura Maria Sangalli; Giorgio Pizzocaro; Luigi Piva; Roberto Salvioni
Journal:  Anal Quant Cytol Histol       Date:  2009-06       Impact factor: 0.302

10.  Radiation therapy in the management of the primary penile tumor: an update.

Authors:  Juanita Crook; Clement Ma; Laval Grimard
Journal:  World J Urol       Date:  2008-07-18       Impact factor: 4.226

View more
  1 in total

Review 1.  [Local treatment of penile cancer].

Authors:  C Protzel; O W Hakenberg
Journal:  Urologe A       Date:  2018-04       Impact factor: 0.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.